Alan Kwan

Prior to QLS, Alan served as an Analyst at Millennium Management, LLC where he designed, managed, and implemented semi-automated infrastructure to support several fundamentals-based trading strategies for his coverage in both large and SMID cap biopharma US equities. Prior to joining Millennium, Alan served as a Vice President of Research at Tekla Capital Management where he covered US SMID cap biotechnology, US life-science tools and diagnostics, and US medtech. He received his B.S. in Computer Science from the University of British Columbia, his M.S. in Computer Science from Washington University in St. Louis, his Ph.D. in Computational Genomics from Washington University School of Medicine, and his MBA from MIT.